Direct-Acting Antivirals in the Treatment of Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) Co-infected Patients: Real-Life Experience From Nepal

Background Direct-acting antivirals (DAA) have revolutionized the treatment of chronic hepatitis C patients. However, the real-life data regarding its use in a human immunodeficiency virus (HIV) co-infection from a developing country is lacking. We aimed to see the efficacy of DAA in hepatitis C vir...

Descripción completa

Detalles Bibliográficos
Autores principales: KC, Sudhamshu, Karki, Niyanta, Sharma, Dilip, Khadka, Sandip, Tiwari, Pratap S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311391/
https://www.ncbi.nlm.nih.gov/pubmed/34336433
http://dx.doi.org/10.7759/cureus.15932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311391/
https://www.ncbi.nlm.nih.gov/pubmed/34336433
http://dx.doi.org/10.7759/cureus.15932

Ejemplares similares